Literature DB >> 32669338

A Stronger Transcription Regulatory Circuit of HIV-1C Drives the Rapid Establishment of Latency with Implications for the Direct Involvement of Tat.

Sutanuka Chakraborty1, Manisha Kabi1, Udaykumar Ranga2.   

Abstract

The magnitude of transcription factor binding site variation emerging in HIV-1 subtype C (HIV-1C), especially the addition of NF-κB motifs by sequence duplication, makes the examination of transcriptional silence challenging. How can HIV-1 establish and maintain latency despite having a strong long terminal repeat (LTR)? We constructed panels of subgenomic reporter viral vectors with varying copy numbers of NF-κB motifs (0 to 4 copies) and examined the profile of latency establishment in Jurkat cells. Surprisingly, we found that the stronger the viral promoter, the faster the latency establishment. Importantly, at the time of commitment to latency and subsequent points, Tat levels in the cell were not limiting. Using highly sensitive strategies, we demonstrate the presence of Tat in the latent cell, recruited to the latent LTR. Our data allude, for the first time, to Tat establishing a negative feedback loop during the late phases of viral infection, leading to the rapid silencing of the viral promoter.IMPORTANCE Over the past 10 to 15 years, HIV-1 subtype C (HIV-1C) has been evolving rapidly toward gaining stronger transcriptional activity by sequence duplication of major transcription factor binding sites. The duplication of NF-κB motifs is unique and exclusive to HIV-1C, a property not shared with any of the other eight HIV-1 genetic families. What mechanism(s) does HIV-1C employ to establish and maintain transcriptional silence despite the presence of a strong promoter and concomitant strong, positive transcriptional feedback is the primary question that we attempted to address in the present manuscript. The role that Tat plays in latency reversal is well established. Our work with the most common HIV-1 subtype, HIV-1C, offers crucial leads toward Tat possessing a dual role in serving as both a transcriptional activator and repressor at different phases of viral infection of the cell. The leads that we offer through the present work have significant implications for HIV-1 cure research.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  HIV-1C; LTR; NF-κB; Tat; latency; positive feedback

Mesh:

Substances:

Year:  2020        PMID: 32669338      PMCID: PMC7495361          DOI: 10.1128/JVI.00503-20

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  83 in total

1.  Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy.

Authors:  D Finzi; J Blankson; J D Siliciano; J B Margolick; K Chadwick; T Pierson; K Smith; J Lisziewicz; F Lori; C Flexner; T C Quinn; R E Chaisson; E Rosenberg; B Walker; S Gange; J Gallant; R F Siliciano
Journal:  Nat Med       Date:  1999-05       Impact factor: 53.440

2.  A directed approach for engineering conditional protein stability using biologically silent small molecules.

Authors:  Lystranne A Maynard-Smith; Ling-Chun Chen; Laura A Banaszynski; A G Lisa Ooi; Thomas J Wandless
Journal:  J Biol Chem       Date:  2007-07-01       Impact factor: 5.157

3.  An AP-1 binding site in the enhancer/core element of the HIV-1 promoter controls the ability of HIV-1 to establish latent infection.

Authors:  Alexandra Duverger; Frank Wolschendorf; Mingce Zhang; Fredric Wagner; Brandon Hatcher; Jennifer Jones; Randall Q Cron; Renee M van der Sluis; Rienk E Jeeninga; Ben Berkhout; Olaf Kutsch
Journal:  J Virol       Date:  2012-12-12       Impact factor: 5.103

4.  Histone deacetylase 1 can repress transcription by binding to Sp1.

Authors:  A Doetzlhofer; H Rotheneder; G Lagger; M Koranda; V Kurtev; G Brosch; E Wintersberger; C Seiser
Journal:  Mol Cell Biol       Date:  1999-08       Impact factor: 4.272

5.  A rapid, reversible, and tunable method to regulate protein function in living cells using synthetic small molecules.

Authors:  Laura A Banaszynski; Ling-Chun Chen; Lystranne A Maynard-Smith; A G Lisa Ooi; Thomas J Wandless
Journal:  Cell       Date:  2006-09-08       Impact factor: 41.582

6.  Development of cell lines that provide tightly controlled temporal translation of the human cytomegalovirus IE2 proteins for complementation and functional analyses of growth-impaired and nonviable IE2 mutant viruses.

Authors:  Rebecca L Sanders; Charles L Clark; Christopher S Morello; Deborah H Spector
Journal:  J Virol       Date:  2008-05-07       Impact factor: 5.103

7.  Transfecting mammalian cells: optimization of critical parameters affecting calcium-phosphate precipitate formation.

Authors:  M Jordan; A Schallhorn; F M Wurm
Journal:  Nucleic Acids Res       Date:  1996-02-15       Impact factor: 16.971

8.  An HIV feedback resistor: auto-regulatory circuit deactivator and noise buffer.

Authors:  Leor S Weinberger; Thomas Shenk
Journal:  PLoS Biol       Date:  2007-01       Impact factor: 8.029

9.  Distinctive variation in the U3R region of the 5' Long Terminal Repeat from diverse HIV-1 strains.

Authors:  Christelle Mbondji-Wonje; Ming Dong; Xue Wang; Jiangqin Zhao; Viswanath Ragupathy; Ana M Sanchez; Thomas N Denny; Indira Hewlett
Journal:  PLoS One       Date:  2018-04-17       Impact factor: 3.240

Review 10.  HIV evolution and diversity in ART-treated patients.

Authors:  Gert van Zyl; Michael J Bale; Mary F Kearney
Journal:  Retrovirology       Date:  2018-01-30       Impact factor: 4.602

View more
  3 in total

Review 1.  Balance between Retroviral Latency and Transcription: Based on HIV Model.

Authors:  Aneta Pluta; Juan P Jaworski; César N Cortés-Rubio
Journal:  Pathogens       Date:  2020-12-29

2.  An emerging and variant viral promoter of HIV-1 subtype C exhibits low-level gene expression noise.

Authors:  Haider Ali; Disha Bhange; Kavita Mehta; Yuvrajsinh Gohil; Harshit Kumar Prajapati; Siddappa N Byrareddy; Shilpa Buch; Udaykumar Ranga
Journal:  Retrovirology       Date:  2021-09-19       Impact factor: 4.602

Review 3.  Addressing an HIV cure in LMIC.

Authors:  Sherazaan D Ismail; Joshua Pankrac; Emmanuel Ndashimye; Jessica L Prodger; Melissa-Rose Abrahams; Jamie F S Mann; Andrew D Redd; Eric J Arts
Journal:  Retrovirology       Date:  2021-08-03       Impact factor: 4.602

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.